Bharat Biotech concludes final analysis for COVAXIN, claims 77.8 pc efficacy from phase-3 clinical trials
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
Tag: Phase 3
Karnataka: Vaccination for 18 plus will not start from May 1
Covid-19 vaccination for the age group of 18-45 will not begin from May 1 as announced earlier due to various ...
Bharat Biotech announces phase 3 results of COVAXIN
Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of ...
Latest News
